Hard gelatin capsules<\/p>\n
COMPOSITION :<\/strong><\/p>\n Each hard gelatin capsule contains: THERAPEUTIC INDICATIONS :<\/strong><\/p>\n For the treatment of and prophylaxis against acute or recurrent, uncomplicated lower urinary tract infections or pyelitis either spontaneous or following surgical procedures. Nitrofurantoin is specifically indicated for the treatment of infections due to susceptible strains of Escherichia coli, Enterococci, Staphylococci, Citrobacter, Klebsiella and Enterobacter.<\/p>\n POSOLOGY AND METHOD OF ADMtNtSTRATION<\/strong> Adults CONTRAINDICATIONS :<\/strong><\/p>\n \u2981 Patients with known hypersensitivity to nitrofurantoin or other nitrofurans. For the treatment of and prophylaxis against acute or recurrent, uncomplicated lower urinary tract infections or pyelitis either spontaneous or following surgical procedures. <\/span><\/span><\/span><\/p>\n","protected":false},"featured_media":9220,"template":"","meta":[],"product_brand":[],"product_cat":[542,548,39,167],"product_tag":[],"class_list":{"0":"post-9219","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-vitamines","7":"product_cat-painoff","8":"product_cat-health-and-beauty","9":"product_cat-medicines","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-simple"},"yoast_head":"\n
\nActive ingredients :
\nMepafuran 100 mg
\nNitrofurantoin 100 mg
\nInactive ingredients :
\nMagnesium stearate. Avicel and Maize starch.<\/p>\n
\nDosage:<\/p>\n
\nAcute Uncomplicated Urinary Tract Infections: 50 mg four times daily for seven days. Severe Chronic Recurrence: 100 mg four times day for seven cays.
\nLong Term Suppression: 50 mg \u2013 100 mg once a day.
\nPophylaxis: 50 mg four times daily for the duration of procedure and 3 days thereafter.
\nChildren and Infants over three months of age
\nAcute Urinary Tract Infections: 3 mg\/kg\/day in four divided doses for seven days. Suppressive: 1 mg\/kg, once a day.
\nFor children under 25 Kg bodyweight consideration should be given to the use of nitrofurantoin suspension.
\nElderty
\nProvided there is no significant renal impairment, in which Nitrofurantoin is contraindicated, the dosage should be that for any normal adult. See precaution and risks to elderly patients associated
\nwith lonq- term therapy.<\/p>\n
\n\u2981 Patients suffering from renal dysfunction with a creatinine clearance of less than 60 ml\/minute or elevated serum creatinine.
\n\u2981 G6PD deficiency.
\n\u2981 Acute porphyria.
\n\u2981 In infants less than 3 months and at the end of pregnancy (during labour and delivery) because of the theoretical possibility of hemolytic anemia in the fetus or newborn (under 3 months) due to immature erythrocyte enzyme system.
\n\u2981 Products containing nitrofurantoin are contraindicated in patients with previous history of cholestatic jaundice\/hepatic dysfunction associated with nitrofurantoin.<\/p>\n","protected":false},"excerpt":{"rendered":"